Written by Jay Campbell
[Disclaimer: This article is for educational purposes only. Always consult with a qualified healthcare provider before starting any peptide protocol.]
Most people dosing Delta Sleep-Inducing Peptide (DSIP) for better nighttime rest are copying underground protocols that have zero connection to actual human research.
For years, I’ve watched the biohacking community embrace this peptide as a tool for optimizing sleep quality.
Yet almost no one acknowledges a critical fact:
The clinical trials demonstrating DSIP’s sleep effects used intravenous administration, and NOT the subcutaneous injections people are doing at home.
And the dosages were calculated per kilogram of body weight, administered in carefully controlled settings using slow infusions.
How to take DSIP the right way is a subject most biohackers aren’t talking enough about.
This article was written to put a stop to this ignorance once and for all.
I’ll break down exactly what the literature shows about DSIP dosing, expose the gap between clinical evidence and community practice, and provide a rational framework for informed decision making.
Quick Takeaways
- Human sleep trials used 25 nmol/kg IV for 7 consecutive nights
- The commonly used 100–250 mcg subcutaneous protocol lacks direct clinical validation
- DSIP demonstrates an unusually wide safety margin in animal and human research
- Most evidence comes from small 1980s pilot studies, not modern RCTs
What DSIP Actually Is (And Why It’s Misunderstood)
DSIP is a nine-amino-acid neuropeptide first isolated in 1977 from the cerebral venous blood of sleeping rabbits.
The name “Delta Sleep-Inducing Peptide” is actually misleading, because this compound does far more than just promote restorative sleep.
Human trials from the 1980s showed the following:
- 97% reduction in withdrawal symptoms in opiate addicts
- 87% improvement in alcohol withdrawal
- Chronic pain reduction in 6 of 7 patients over 5–10 days
- Improved stress resilience and psychomotor performance
Sleep modulation is an important part of DSIP’s psychophysiological activity, but it’s just one aspect.
And here’s the critical point most people miss:
DSIP’s exact mechanisms of action remain unresolved, with species-specific effects that make extrapolation from animal studies to humans a problematic endeavor.
The Clinical Evidence for DSIP Dosing
The gold-standard human evidence for DSIP and sleep used protocols you’re probably not replicating (or reading about in online forums).
The landmark DSIP sleep study used 25 nmol/kg IV for 7 consecutive nights, measured via polysomnography.
For a 90 kg (198 lb) man, that’s approximately 2,250 nmol total, which converts to roughly 190–210 mcg per dose depending on the exact molecular calculations.
Another clinical protocol used four consecutive intravenous injections that normalized disturbed sleep patterns, with effects lasting up to 20 hours and good compatibility when the peptide was injected slowly.
Human trials testing DSIP for various applications used doses ranging from 25–100 nmol/kg intravenously, with no doses exceeding 21.4 mcg/kg daily.
Notice what’s missing from all these studies?
Any mention of SUBCUTANEOUS administration!
The intravenous route ensures 100% bioavailability and involves controlled pharmacokinetics you simply cannot replicate with a subcutaneous injection.
The Subcutaneous Dosing Reality
Now here’s where things gets interesting…
The commonly cited “research-use only dosages” of 100–250 mcg subcutaneously once daily for sleep optimization are based on case reports and observational studies, not on controlled trials that demonstrated the efficacy of DSIP
Does this necessarily invalidate the subcutaneous use of DSIP?
No, but it does mean you are operating outside validated protocols.
Subcutaneous administration suffers from:
- Lower bioavailability
- Variable absorption
- Different pharmacokinetics
Which means the systemic exposure of DSIP via subcutaneous administration is not equivalent to what is achieved with intravenous infusion.
DSIP Dosage Chart by Administration Route
Here’s a practical framework based on the available evidence:
| Parameter | Intravenous (Clinical Protocol) | Subcutaneous (Community Protocol) |
| Dose | 25–100 nmol/kg
~190–750 mcg for a 90 kg individual |
100–250 mcg |
| Frequency | Daily for 4–7 consecutive nights | Daily in the evening, 30–60 min before bed |
| Duration of Effects | Up to 20 hours | Variable; reassess after 5–7 days |
| Evidence Level | Moderate
Small human trials from the 1980s |
Low
Case reports and observational use |
The subcutaneous protocol used today is based on decades of field experimentation by clinicians, peptide researchers, and experienced biohackers.
The Jay Campbell DSIP Peptide Protocol
Here’s the typical optimization protocol used in the Jay Campbell ecosystem:
- Dose: 250 mcg
- Route: Subcutaneous injection
- Timing: 1–3 hours before bed
- Frequency: 5 days on / 2 days off
- Cycle: 8 weeks on / 8 weeks off
Some individuals experiment with lower starting doses, but 250 mcg is the standard starting point.
Important Calculation Note
If you’re working with lyophilized DSIP powder that requires reconstitution, you need to know your starting concentration.
Most vials contain 2 mg (2,000 mcg) of DSIP, and if you reconstitute with 2 mL of bacteriostatic water, you get a concentration of 1,000 mcg/mL (or 1 mcg per 0.001 mL).
For a 200 mcg dose, you would draw out 0.2 mL (20 units on a standard insulin syringe) for your injection.
Always, ALWAYS confirm the concentration of the peptide you’re using before dosing it.
DSIP Mechanisms (What We Actually Know)
Animal models show the following:
- Dose-dependent antinociceptive effects (pain reduction)
- Naloxone blockade, indicating opioid receptor involvement
The effects on human subjects appear to be broader:
- Stress modulation
- Neurotransmitter regulation
- Possible circadian interaction
The exact receptor targets remain undefined as of now, which means the optimal subcutaneous dose of DSIP has not been scientifically established.
Safety Profile and Side Effects
This is one area where the data is reassuringly consistent.
No dosage of DSIP has killed animals in research studies, indicating an exceptionally wide therapeutic window.
Human side effects are limited to transient headache, nausea, and vertigo in a small percentage of users (typically when the peptide is administered too rapidly).
The slow intravenous infusion protocols used in clinical trials minimized these effects, suggesting that rapid bolus administration (which is essentially what subcutaneous injection creates) may increase the likelihood of transient side effects.
I’ve personally never experienced significant adverse effects from DSIP, and in my decades of working with therapeutic peptides, it stands out as a benign compound in terms of safety profile.
At the same time, the lack of long-term studies means we’re operating with incomplete data when it comes to the extended and/or repeated use of DSIP.
The Evidence Gap You Must Understand
The evidence base for DSIP is limited and dated, despite all the citations I’ve quoted so far.
The clinical research currently consists of the following:
- Small 1980s pilot trials
- No large modern RCTs
- Limited pharmacokinetic clarity
- No validated subcutaneous dosing protocol for improved sleep
DSIP likely works for many individuals, but it’s critical to acknowledge the doses used by the biohacking community comes from extrapolation.
Using DSIP Peptide Therapy Safely
If you’re considering DSIP for sleep optimization, here’s the framework I recommend based on decades of peptide experimentation and the protocols I’ve personally used.
Start with the standard protocol used in my peptide cheat sheet:
- Dose: 250 mcg
- Administration: Subcutaneous injection
- Timing: 1–3 hours before bed
- Frequency: 5 days on, 2 days off
- Cycle length: 8 weeks on, followed by 8 weeks off
This 250 mcg dose is the most commonly used starting point because it balances effectiveness with a very favorable safety profile.
Some individuals who are highly sensitive to neuroactive peptides may prefer to begin slightly lower (100–150 mcg) for the first few doses to assess tolerance before moving to the full protocol.
Since DSIP appears to influence sleep architecture and circadian signaling, injecting 1–3 hours before your target sleep time tends to produce the best results.
When experimenting with DSIP, track objective changes across the following biomarkers:
- Sleep latency (i.e. how quickly you fall asleep)
- Nighttime awakenings
- Morning recovery and alertness
- HRV or sleep tracker data
If you notice improvements within the first week, continue the cycle.
If nothing changes after 7–10 days, DSIP may simply not be the right fit for your individual biochemistry and genetic profile.
As with many other neuropeptides, individual response can vary.
The key is to treat optimization like an experiment — measure, adjust, and let your physiology guide the protocol changes (if any).
Who Should Consider DSIP (And Who Shouldn’t)
DSIP makes the most sense for individuals with chronic insomnia or significantly disrupted sleep architecture who haven’t responded adequately to other interventions.
The historical evidence also suggests potential benefits for people dealing with chronic pain, stress-related sleep disruption, or even substance withdrawal (though the latter should only be attempted under medical supervision).
Avoid DSIP under the following circumstances:
- Currently pregnant/breastfeeding
- Known history of being hypersensitive to peptides
- Unable to properly source the peptide from a reliable vendor
And remember: DSIP is NOT a first-line therapeutic intervention!
Sleep hygiene, light management, temperature, minerals, and circadian alignment should be established as the foundation for your sleep hygiene.
The Bottom Line on DSIP Dosing
Clinical DSIP sleep research used intravenous dosing calculated on a per-kilogram basis.
The recommended subcutaneous dose of 100–250 mcg is extrapolated from both available research and anecdotal reports.
That does not invalidate DSIP’s use as a subcutaneously injected peptide, but it changes the degree of certainty you should expect with the results you get.
Despite this lack of validation and an incomplete understanding of its mechanisms of action, the safety profile nevertheless remains high.
Safety profile: high Mechanism: incomplete Optimal SC dose: unvalidated
If you choose to use it, do so consciously: Start at the minimum effective dose, track your outcomes, and adjust your protocol based on YOUR physiology.
And as I said earlier, don’t use DSIP if you can’t acquire it through the proper means.
Just as you wouldn’t put low-grade fuel in a precision engine, you sure wouldn’t put anything less than the purest peptides in your body.
That’s why source quality and manufacturing standards matter.
I’ve personally vetted dozens of peptide suppliers, and I can tell you this without hesitation: BioLongevity Labs sets the benchmark for authentic therapeutic peptides, with a ruthless focus on stringent third-party testing and top-notch customer service.
They consistently deliver the highest quality products, trusted by professionals for both personal and clinical use.
Whether you’re looking to elevate your performance or integrate these products into research applications, BioLongevity Labs is a reliable source you can count on.
👉 Click here to place your online order for DSIP 👈
Use code JayC to get 15% off your order!
I also invite you to join me and other like-minded biohackers in The Fully Optimized Health Private Membership Group.
You’ll receive guidance from myself and an elite group of more than 700 male and female biohackers (who all started out just like you).
And don’t forget to check out my premium educational content dedicated to helping you fully optimize your health:
Quantum Peptides – the A-to-Z system for anyone (newbies & pros alike) desiring to master peptide use for the first time and forever.
Quantum Testosterone – the A-to-Z system for Men & Women to learn to optimize their hormones for explosive energy, lean muscle, and timeless vitality.
The Ultimate GLP-1 Video Masterclass – how to PROPERLY utilize the world’s most powerful weight loss drugs for enhanced fat loss and overall longevity.
The Modern Woman’s Peptide Course – a must-have resource for any woman seeking to become more feminine, sexier, leaner, and healthier through the use of peptides.
Life Enhanced – Unlock the secrets to TOTAL Mind-Body-Spirit Optimization as Hunter Williams and I teach you how to live at the tip of the spear.
30 Days 2 Shredz – Reprogram Your Mind and Body for Maximum Fat Loss in Minimum Time with our Optimized Fasting Protocol
Monica Campbell’s 3 Day PMF Video Training Program – Ignite unbreakable strength, sculpt lean muscle, and conquer workouts fearlessly with my wife Monica’s 3 Day Video training course.
Positive Muscle Failure Video Training Program – Learn how to lift weights correctly for maximum muscle in minimum time while building the physique of your dreams.
See you on the inside!
